{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T04:57:57Z","timestamp":1740113877763,"version":"3.37.3"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health & Medical Research Council","doi-asserted-by":"publisher","award":["1034642"],"award-info":[{"award-number":["1034642"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.neuropharm.2016.05.019","type":"journal-article","created":{"date-parts":[[2016,5,29]],"date-time":"2016-05-29T01:06:32Z","timestamp":1464483992000},"page":"49-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Mechanism of direct Cav2.2 channel block by the \u03ba-opioid receptor agonist U50488H"],"prefix":"10.1016","volume":"109","author":[{"given":"G\u00e9za","family":"Berecki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonid","family":"Motin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2016.05.019_bib1","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1085\/jgp.201311104","article-title":"Differential Cav2.1 and Cav2.3 channel inhibition by baclofen and \u03b1-conotoxin Vc1.1 via GABAB receptor activation","volume":"143","author":"Berecki","year":"2014","journal-title":"J.\u00a0Gen. Physiol."},{"key":"10.1016\/j.neuropharm.2016.05.019_bib42","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1124\/mol.115.101154","article-title":"Voltage-gated R-type calcium channel inhibition via human \u00b5-, \u03b4-, and \u03ba-opioid receptors is voltage-independently mediated by G\u03b2\u03b3 protein subunits","volume":"89","author":"Berecki","year":"2016","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.05.019_bib2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1152\/physrev.00023.2013","article-title":"Calcium-permeable ion channels in pain signaling","volume":"94","author":"Bourinet","year":"2014","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2016.05.019_bib3","doi-asserted-by":"crossref","first-page":"18081","DOI":"10.1074\/jbc.M513640200","article-title":"Kappa opioid receptor activation of p38 MAPK is GRK3- and arrestin-dependent in neurons and astrocytes","volume":"281","author":"Bruchas","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2016.05.019_bib4","doi-asserted-by":"crossref","first-page":"10943","DOI":"10.1523\/JNEUROSCI.3594-08.2008","article-title":"Analgesic \u03b1-conotoxins Vc1.1 and Rg1A inhibit N-type calcium channels in rat sensory neurons via GABAB receptor activation","volume":"28","author":"Callaghan","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2016.05.019_bib5","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1523\/JNEUROSCI.6146-08.2009","article-title":"Endogenous kappa opioid activation mediates stress-induced deficits in learning and memory","volume":"29","author":"Carey","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2016.05.019_bib6","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1097\/00001756-199607290-00024","article-title":"Opioid receptor independent inhibition of Ca2+ and K+ currents in NG108-15 cells by the kappa opioid receptor agonist U50488H","volume":"7","author":"Carpenter","year":"1996","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2016.05.019_bib7","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1021\/jm00399a025","article-title":"Highly selective kappa opioid analgesics. Synthesis and structure-activity relationships of novel N-[(2-aminocyclohexyl)aryl]acetamide and N-[(2-aminocyclohexyl)aryloxy]acetamide derivatives","volume":"31","author":"Clark","year":"1988","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.neuropharm.2016.05.019_bib8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1089\/adt.2008.136","article-title":"A\u00a0high-throughput assay for evaluating state dependence and subtype selectivity of Cav2 calcium channel inhibitors","volume":"6","author":"Dai","year":"2008","journal-title":"Assay Drug Dev. Technol."},{"key":"10.1016\/j.neuropharm.2016.05.019_bib9","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1021\/acschemneuro.5b00113","article-title":"Activation of \u03ba opioid receptors in cutaneous nerve endings by conorphin-1, a novel subtype-selective conopeptide, does not mediate peripheral analgesia","volume":"6","author":"Deuis","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2016.05.019_bib11","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/brb3.222","article-title":"The role of \u03ba opioid receptors in stress-induced reinstatement of alcohol seeking in rats","volume":"4","author":"Funk","year":"2014","journal-title":"Brain Behav."},{"key":"10.1016\/j.neuropharm.2016.05.019_bib12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/AAP.0b013e318274a8a1","article-title":"The kappa-opioid receptor agonist U-50488 blocks Ca2+ channels in a voltage- and G protein-independent manner in sensory neurons","volume":"38","author":"Hassan","year":"2013","journal-title":"Reg. Anesth. Pain Med."},{"key":"10.1016\/j.neuropharm.2016.05.019_bib13","first-page":"551","article-title":"\u039a-opioid receptors couple to inwardly rectifying potassium channels when coexpressed by Xenopus oocytes","volume":"47","author":"Henry","year":"1995","journal-title":"Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.neuropharm.2016.05.019_bib14","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1469-7793.2000.t01-1-00237.x","article-title":"Molecular determinants of inactivation in voltage-gated Ca2+ channels","volume":"528","author":"Hering","year":"2000","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2016.05.019_bib16","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1124\/jpet.115.225896","article-title":"Functional selectivity of \u03ba opioid receptor agonists in peripheral sensory neurons","volume":"355","author":"Jamshidi","year":"2015","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2016.05.019_bib17","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.bcp.2010.07.038","article-title":"Identification of a \u03ba-opioid agonist as a potent and selective lead for drug development against human African trypanosomiasis","volume":"80","author":"Jones","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.05.019_bib18","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0006-8993(95)01049-3","article-title":"\u03ba-opioid agonist U50488 inhibits P-type Ca2+ channels by two mechanisms","volume":"702","author":"Kanemasa","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2016.05.019_bib19","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1523\/JNEUROSCI.4458-07.2008","article-title":"The dysphoric component of stress is encoded by activation of the dynorphin \u03ba-opioid system","volume":"28","author":"Land","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2016.05.019_bib20","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1460-9568.2006.05299.x","article-title":"\u03c9-Conotoxin CVIB differentially inhibits native and recombinant N- and P\/Q-type calcium channels","volume":"25","author":"Motin","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2016.05.019_bib21","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1113\/jphysiol.1978.sp012267","article-title":"Local anaesthetics transiently block currents through single acetylcholine-receptor channels","volume":"277","author":"Neher","year":"1978","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2016.05.019_bib23","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1124\/mol.114.096008","article-title":"G\u00a0protein regulation of neuronal calcium channels: back to the future","volume":"87","author":"Proft","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.05.019_bib25","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0014-2999(94)90121-X","article-title":"An electrophysiological basis for the antiarrhythmic actions of the \u03ba-opioid receptor agonist U-50,488H","volume":"261","author":"Pugsley","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.05.019_bib26","first-page":"61","article-title":"Potent and use-dependent block of cardiac sodium channels by U-50,488H, a benzeneacetamide \u03ba opioid receptor agonist","volume":"6","author":"Pugsley","year":"2001","journal-title":"Exp. Clin. Cardiol."},{"key":"10.1016\/j.neuropharm.2016.05.019_bib27","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.neuroscience.2014.11.053","article-title":"The effects of morphine, naloxone, and \u03ba opioid manipulation on endocrine functioning and social behavior in monogamous titi monkeys (Callicebus cupreus)","volume":"287","author":"Ragen","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2016.05.019_bib28","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1113\/jphysiol.1992.sp018944","article-title":"Calcium current variation between acutely isolated adult rat dorsal root ganglion neurons of different size","volume":"445","author":"Scroggs","year":"1992","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2016.05.019_bib29","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1523\/JNEUROSCI.18-10-03689.1998","article-title":"Structural features determining differential receptor regulation of neuronal Ca channels","volume":"18","author":"Simen","year":"1998","journal-title":"J.\u00a0Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2016.05.019_bib30","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1469-7793.2000.t01-1-00445.x","article-title":"Modulation of slow inactivation in class A Ca2+ channels by beta-subunits","volume":"527","author":"Sokolov","year":"2000","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2016.05.019_bib33","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1152\/jn.00624.2001","article-title":"Sodium channel blocking actions of the \u03ba-opioid receptor agonist U50,488 contribute to its visceral antinociceptive effects","volume":"87","author":"Su","year":"2002","journal-title":"J.\u00a0Neurophysiol."},{"key":"10.1016\/j.neuropharm.2016.05.019_bib34","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/0306-4522(94)90570-3","article-title":"The cloned kappa opioid receptor couples to an N-type calcium current in undifferentiated PC-12 cells","volume":"63","author":"Tallent","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2016.05.019_bib35","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/bph.12810","article-title":"Anti-nociception mediated by a \u03ba opioid receptor agonist is blocked by a \u03b4 receptor agonist","volume":"172","author":"Taylor","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.05.019_bib36","series-title":"Calcium Channel Pharmacology","first-page":"1","article-title":"Concepts of state-dependent pharmacology of calcium channels. Kluwer Academic\/Plenum Publishers","author":"Timin","year":"2004"},{"key":"10.1016\/j.neuropharm.2016.05.019_bib37","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0014-2999(99)00736-0","article-title":"The dual modulation of GIRK1\/GIRK2 channels by opioid receptor ligands","volume":"385","author":"Ulens","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.05.019_bib38","first-page":"627","article-title":"Inhibition of L-type calcium currents in guinea pig ventricular myocytes by the \u03ba-opioid agonist U50488H does not involve binding to opiate receptors","volume":"274","author":"Utz","year":"1995","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2016.05.019_bib39","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/jcp.22247","article-title":"Voltage-dependent \u03ba-opioid modulation of action potential waveform-elicited calcium currents in neurohypophysial terminals","volume":"225","author":"Velazquez-Marrero","year":"2010","journal-title":"J.\u00a0Cell Physiol."},{"key":"10.1016\/j.neuropharm.2016.05.019_bib40","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/372097a0","article-title":"Molecular determinants of voltage-dependent inactivation in calcium channels","volume":"372","author":"Zhang","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2016.05.019_bib41","doi-asserted-by":"crossref","first-page":"e0134117","DOI":"10.1371\/journal.pone.0134117","article-title":"\u201cSlow\u201d voltage-dependent inactivation of Cav2.2 calcium channels is modulated by the PKC activator phorbol 12-myristate 13-acetate (PMA)","volume":"10","author":"Zhu","year":"2015","journal-title":"PLoS One"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390816302258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390816302258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,2]],"date-time":"2019-11-02T19:03:38Z","timestamp":1572721418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390816302258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":36,"alternative-id":["S0028390816302258"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2016.05.019","relation":{},"ISSN":["0028-3908"],"issn-type":[{"type":"print","value":"0028-3908"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanism of direct Cav2.2 channel block by the \u03ba-opioid receptor agonist U50488H","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2016.05.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}